Table 1.
An overview of formulas and cutoffs for determining non-invasive marker panels for detection of liver fibrosis[10-12,21,22]
|
Formula
|
Equation
|
Lower cutoff
|
Higher cutoff
|
| FIB-4 | [Age (yr) × AST (IU/L)]/{platelet count (109/L) × [ALT(IU/L)]1/2} | 1.3 | 2.67[11] |
| 1.45 | 3.25[22] | ||
| APRI | [(AST/ULN)/platelet count (109/L)] × 100 | 0.5 | 1.5[21] |
| NFS | -1.675 + 0.037 × age (yr) + 0.094 × BMI (kg/m2) + 1.13 × IFG/diabetes (yes = 1, no = 0) + 0.99 × AST/ALT-0.013 × platelet count (× 109/L) - 0.66 × albumin (g/dL) | -0.676 | 1.455[10] |
| BARD | Scale 0-4; BMI ≥ 28 kg/m2 = 1 point; AST/ALT ≥ 0.8 = 2 points; Diabetes = 1 point | 2[12] | |
ALT: Alanine aminotransferase; APRI: Aspartate aminotransferase to platelet ratio index; AST: Aspartate aminotransferase; BARD: Body mass index, aspartate aminotransferase/alanine aminotransferase ratio, diabetes score; BMI: Body mass index; FIB-4: Fibrosis-4 index; IFG: Impaired fasting glucose; NFS: Nonalcoholic fatty liver disease fibrosis score; ULN: Upper limit of normal.